Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.64 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.64 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.64 |
| ▸ | ALB | P02768 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | RARB | P10826 | 1/20 | 0.64 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butibufen SCHEMBL7346774 | 0.84 | PTGS1 (0.73) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| Butibufen SCHEMBL24177 | 0.84 | PTGS1 (0.73) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL9305042 | 0.83 | PTGS1 (0.71) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL27810577 | 0.83 | PTGS1 (1.00) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| Butibufen SCHEMBL1605646 | 0.83 | PTGS1 (0.71) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL27810576 | 0.83 | PTGS1 (1.00) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL9474541 | 0.83 | PTGS1 (0.71) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL8814074 | 0.82 | ESR1 (0.60) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| SCHEMBL27934588 | 0.81 | PTGS1 (0.69) | PTGS1PTGS2ALOX5LMNACYP2C9 | |
| Ibuprofen SCHEMBL19439560 | 0.78 | PTGS1 (1.00) | PTGS1PTGS2ALOX5LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120128588-A1 | ISOTOPE LABELED 2-ARYLPROPIONIC ACID COMPOUNDS AND PROCESS FOR PRODUCTION OF SAME, AND MOLECULAR PROBE FOR POSITRON EMISSION TOMOGRAPHY AND METHOD FOR IMAGING OF CYCLOOXYGENASE AND THE LIKE USING SAME | RIKEN (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120128588-A1 | ISOTOPE LABELED 2-ARYLPROPIONIC ACID COMPOUNDS AND PROCESS FOR PRODUCTION OF SAME, AND MOLECULAR PROBE FOR POSITRON EMISSION TOMOGRAPHY AND METHOD FOR IMAGING OF CYCLOOXYGENASE AND THE LIKE USING SAME | CYP2F1, PTGS2, PTGER2 | PTGS1 5/4885PTGS2 2/4885ALOX5 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.